Immediate Impact

2 from Science/Nature 70 hit
Sub-graph 1 of 20

Citing Papers

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Hit
Prostate Cancer
2025 Hit
2 intermediate papers

Works of John Matthews being referenced

A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study
2010
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial
2005

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John Matthews 344 220 106 101 96 37 804
Hollis W. Merrick 153 0.4× 258 1.2× 54 0.5× 69 0.7× 256 2.7× 47 755
Juan Manuel Praena‐Fernández 193 0.6× 223 1.0× 38 0.4× 20 0.2× 127 1.3× 73 918
John W. Colberg 548 1.6× 250 1.1× 51 0.5× 147 1.5× 108 1.1× 35 968
Javier Casillas 303 0.9× 485 2.2× 19 0.2× 22 0.2× 159 1.7× 43 853
R. Salvador 400 1.2× 415 1.9× 35 0.3× 7 0.1× 87 0.9× 54 1.0k
Salman Zaheer 261 0.8× 479 2.2× 14 0.1× 52 0.5× 371 3.9× 32 844
Michael Perrotti 512 1.5× 516 2.3× 14 0.1× 65 0.6× 55 0.6× 33 983
Geoffrey M. Silver 167 0.5× 135 0.6× 20 0.2× 10 0.1× 97 1.0× 28 890
Fabio Crocerossa 444 1.3× 222 1.0× 22 0.2× 8 0.1× 70 0.7× 52 757
Stephan Gripp 235 0.7× 294 1.3× 21 0.2× 62 0.6× 265 2.8× 31 815

All Works

Loading papers...

Rankless by CCL
2026